Neuros Medical, Inc., a medical device company announced the issuance of a new U.S. Patent for their High Frequency Electrical Nerve Block technology.
According to a company release, the US Patent No. 8,731,676 titled "High-Frequency Electrical Nerve Block," features broad claims, focusing on blocking nerve activity, in nerve sizes 3mm up to 12mm in diameter, for a variety of applications, including pain, spasticity, and bladder. Neuros now has three issued patents in its portfolio, with others pending.
Neuros said it is in the initial stages of their randomized, controlled pivotal clinical trial to evaluate the Company's patented Altius High Frequency Nerve Block System for the management of intractable limb pain of amputees. The study consists of 130 patients at 15 medical centers in the U.S. When completed, the results will support a PreMarket Approval Application to FDA in order to market the device. The pivotal study builds upon their long- term pilot study which reported significant pain reduction. In addition, more than half of the subjects discontinued their pain medication use during the study.
Jon J. Snyder, President and CEO of Neuros Medical, said "We are extremely pleased with the issuance of this new patent, which adds to our existing portfolio and continues to bolster our strong patent claims and intellectual property protection."
((Comments on this story may be sent to firstname.lastname@example.org))